The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
9-(Furan-2-yl)-7-(phenylamino)phenanthridin-6(5H)-one ID: ALA4742183
PubChem CID: 162645502
Max Phase: Preclinical
Molecular Formula: C23H16N2O2
Molecular Weight: 352.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]c2ccccc2c2cc(-c3ccco3)cc(Nc3ccccc3)c12
Standard InChI: InChI=1S/C23H16N2O2/c26-23-22-18(17-9-4-5-10-19(17)25-23)13-15(21-11-6-12-27-21)14-20(22)24-16-7-2-1-3-8-16/h1-14,24H,(H,25,26)
Standard InChI Key: ZAPNBHGFIWFOTQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
5.0916 -2.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0904 -3.2174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5053 -2.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7967 -1.9890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5081 -3.2169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7950 -3.6235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2107 -4.4493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2168 -3.6267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4975 -4.8558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7925 -4.4380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0803 -4.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0718 -5.6588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7816 -6.0748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4909 -5.6709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9157 -4.8624 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1957 -6.0844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3649 -6.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6292 -5.7211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0807 -6.3206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4815 -7.0276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2776 -6.8648 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1900 -6.9016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4777 -7.3026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4716 -8.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1770 -8.5334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8899 -8.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8925 -7.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
5 8 1 0
6 10 1 0
9 7 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
7 15 2 0
14 16 1 0
12 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 1 0
16 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.39Molecular Weight (Monoisotopic): 352.1212AlogP: 5.68#Rotatable Bonds: 3Polar Surface Area: 58.03Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 6.19CX LogD: 6.19Aromatic Rings: 5Heavy Atoms: 27QED Weighted: 0.41Np Likeness Score: -0.63
References 1. Rocchi D,Blázquez-Barbadillo C,Agamennone M,Laghezza A,Tortorella P,Vicente-Zurdo D,Rosales-Conrado N,Moyano P,Pino JD,González JF,Menéndez JC. (2021) Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity., 210 [PMID:33310289 ] [10.1016/j.ejmech.2020.113061 ]